407008006: Efalizumab 125mg/vial lyophilized powder for injection (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2150838016 Efalizumab 125mg/vial lyophilized powder for injection (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2154139018 Efalizumab 125mg/vial lyophilised powder for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2155162014 Efalizumab 125mg/vial lyophilized powder for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2536699016 Efalizumab 100mg/mL powder+solvent for injection solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

4723301000005115 efalizumab 125 mg lyofiliseret pulver til injektionsvæske, hætteglas da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
efalizumab 125 mg lyofiliseret pulver til injektionsvæske, hætteglas	Is a	Product containing efalizumab (medicinal product)	false	Inferred relationship	Some
efalizumab 125 mg lyofiliseret pulver til injektionsvæske, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Efalizumab (substance)	false	Inferred relationship	Some
efalizumab 125 mg lyofiliseret pulver til injektionsvæske, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Immunosuppressant (substance)	false	Inferred relationship	Some
efalizumab 125 mg lyofiliseret pulver til injektionsvæske, hætteglas	Has manufactured dose form	injektionsvæske	false	Inferred relationship	Some
efalizumab 125 mg lyofiliseret pulver til injektionsvæske, hætteglas	Is a	Product manufactured as parenteral dose form (product)	false	Inferred relationship	Some
efalizumab 125 mg lyofiliseret pulver til injektionsvæske, hætteglas	Has manufactured dose form	pulver til injektionsvæske	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Raptiva 125mg/vial lyophilized powder for injection	Is a	False	efalizumab 125 mg lyofiliseret pulver til injektionsvæske, hætteglas	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set